Characterizing human colorectal carcinomas by proteolytic profile

In Vivo

Volumn 11, Issue 3, 1997, Pages 209-216

  Murnane, Mary Jo ^a,b   Shuja, Sania ^a,b   Del Re, Elisabetta ^a   Cai, Jinguo ^a   Iacobuzio Donahue, Christine ^a   Klepeis, Veronica ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

Cathepsins; Colorectal cancer; Matrix metalloproteinases; Proteinases

Indexed keywords

CATHEPSIN B; CATHEPSIN H; CATHEPSIN L; CYSTEINE PROTEINASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

ARTICLE; CANCER STAGING; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 0030787052     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ellis HM and Horvitz HR: Genetic control of programmed cell death in the nematode C. Elegans. Cell 44: 817-829, 1995.
2. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL and Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376; 37-43, 1995.
3. Meerabux J, Yaspo M-I, Roebroek AJ, Van de Ven WJM, Lister A and Young BD: A new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas. Cancer Res 56: 448-451, 1996.
4. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS and Skriver L: Plasminogen activators, tissue degradation and cancer. Advanc. Cancer Res 44: 139-266, 1985.
5. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, and Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (Lond.) 370: 61-65, 1994.
6. Van der Stappen JWJ, Williams A.C, Maciewicz RA and Paraskeva C: Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Internat J Cancer 67: 547-554, 1996.
7. Liotta LA and Stetler-Stevenson WG: Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res 51: 5054-5059, 1991.
8. Dukes CE: The classification of cancer of the rectum. J Pathol Bacteriol 35: 323-332, 1932.
9. Turnbull RB, Jr., Kyle K, Watson FR, Spratt J: Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 166: 420-427, 1967.
10. Nichols EA and Ruddle FH: A review of enzyme polymorphism, linkage and electrophoretic conditions for mouse and somatic cell hybrids in starch gels, J Histochem Cytochem 21: 1066-1081, 1973.
11. Lowry O, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
12. MacGregor RR, Hamilton JW, Shofstall RE and Cohn DV: Isolation and characterization of porcine parathyroid cathepsin B. J Biol Chem 254: 4423-4427, 1979.
13. Barrett AJ and Kirschke H: Cathepsin B, cathepsin H, cathepsin L. Methods Enzymol 80: 535-561, 1981.
14. Sheahan K, Shuja S, and Murnane MJ: Cysteine Protease Activities and Tumor Development in Human Colorectal Carcinoma. Cancer Res 49: 3809-3814, 1989.
15. Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M and Hanada K: L-trans-Epoxysuccinyl-leucylamido (4-guanidino) butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J 201: 189-198, 1982.
16. Murnane MJ, Cai J, Shuja S, Cote L, del Re E, Iacobuzio C, Kim K and Sheahan K. Changing patterns of proteolytic expression in colorectal tumor progression. In: Proteases Involved in Cancer. Suzuki M and Hiwasa T (ed) Monduzzi Editore, Bologna, 1994.
17. Rao JS, Stech PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, and Sawaya R: Elevated levels of Mr 92,000 type IV collagenase in human brain tumors. Cancer Res 53: 2208-2211, 1993.
18. Campbell RC: Statistics for Biologists. Cambridge University Press, New York, 1967.
19. Freund JE: Mathematical Statistics. Prentice-Hall, Englewood Cliffs, N.J., 1971.
20. Liotta LA, Steeg PS and Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
21. Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC and Miskin R. Effects of inhibitors of plasminogen activator, serine proteinases and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48: 3307-3312, 1988.
22. Mignatti P, Robbins E, and Rifkin DB. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 47: 487-498, 1986.
23. Ledakis P, Tester WT, Rosenberg N, Romero-Fischman, Daskal I and Lah TT: Cathepsins D, B and L in malignant human lung tissue. Clin Cancer Res 2: 561-568, 1996.
24. Jeziorska M, Haboubi NY, Schofield PF, Ogata Y, Nagase H and Wooley DE: Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma. Int J Colored Dis 9: 141-148, 1994.
25. Leto G, Tumminello FM, Russo A, Pizzolanti G, Bazan, V and Gebbia N: cathepsin D activity levels in colorectal cancer: Correlation with cathepsin B and L and other biological and clinical parameters. Inter J Oncology 5: 509-515, 1994.
26. Murnane MJ, Sheahan K, Ozdemirli M, and Shuja S: Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res 52: 1137-1142, 1991.
27. Murnane MJ, Cai J, Shuja S, Cote L, Del Re E, Iacobuzio-Donahue C, Kim K and Sheahan K. Changing patterns of proteolytic expression with colorectal tumor progression. In Proteases Involved in Cancer (M Suzuki and T Hiwasa, ed) pp11-26 Monduzzi Editore Bologna, 1994.
28. Iacobuzio-Donahue CA, Shuja S, Cai J, Peng P and Murnane MJ. Elevated protein content and glycosylation of cathepsin B correlate with enzyme activity in the transition from colorectal adenoma to carcinoma. Submitted for publication, 1996.
29. Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane BF and Emmert-Buck MR: Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Amer J Path 145: 201-309, 1994.
30. Duffy MJ: Proteases as prognostic markers in cancer. Clin Cancer Res 2: 613-618, 1996.
31. Kennedy AR: Cancer prevention by protease inhibitors. Prevent Med 22: 796-811, 1993.
32. DeClerck YA and Imren S. Protease inhibitors: role and potential use in human cancer. Eur J Cancer 30A: 2170-2180, 1994.